<![CDATA[What Does TALAPRO-3 Mean for Frontline Treatment of HRR-Altered mHSPC?]]>

Summary

The article discusses TALAPRO-3's potential role in frontline treatment of HRR-altered metastatic hormone-sensitive prostate cancer, featuring a quote from Dr. Neeraj Agarwal on the value of early therapeutic intervention. No specific trial data, regulatory decisions, or company information is provided.